Glimepiride & Metformin Hydrochloride Prolonged Release Tablets IP – Glumight M1 Forte Tablets

Glumight M1 Forte Tablets
Composition: Glimepiride & Metformin Hydrochloride Prolonged Release Tablets IP

Glumight M1 Forte — Glimepiride & Metformin Hydrochloride Prolonged Release Tablets IP is used for the management of type 2 diabetes mellitus. Glimepiride stimulates insulin release, while metformin prolonged-release helps reduce glucose production and improves insulin sensitivity. Together, they provide steady and effective blood sugar control, helping maintain stable glucose levels and reducing the risk of long-term diabetes-related complications when taken regularly with proper diet and lifestyle.

Key Points of Glimepiride & Metformin Hydrochloride Prolonged Release Tablets IP – Glumight M1 Forte Tablets : Reliable Support for Long-Term Diabetes Management

Active Ingredients:

• Glimepiride — Sulfonylurea
  Metformin Hydrochloride (Prolonged-Release) — Biguanide

 Therapeutic Benefits: Helps manage type 2 diabetes mellitus by improving insulin secretion and enhancing insulin sensitivity. Supports effective control of both fasting and post-meal blood glucose levels, promoting long-term glycaemic stability.
Better Tolerability: The prolonged-release Metformin formulation allows gradual drug release, reducing gastrointestinal discomfort and improving patient compliance when used under medical supervision.
Mode of Action: Glimepiride stimulates insulin release from pancreatic beta cells, while Metformin (PR) reduces hepatic glucose production and improves insulin sensitivity—together providing balanced and sustained blood sugar control.

Can be prescribed by:

• Diabetologists
• Endocrinologists
• General Physicians.
• Healthcare practitioner

Disclaimer: To be used strictly under the guidance of a qualified healthcare professional. For prescription use only. Not intended for public marketing or promotion only.